Induction of a primary human cytotoxic T-lymphocyte response against a novel conserved epitope in a functional sequence of HIV-1 reverse transcriptase

AIDS

Volumn 9, Issue 2, 1995, Pages 121-127

  Van Der Burg, Sjoerd H ^a   Klein, Michèl R ^b   Van De Velde, Cornelis J H ^a   Kast, W Martin ^a   Miedema, Frank ^b   Melief, Cornelis J M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b CENTRAL LABORATORY   (Netherlands)

Author keywords

Cytotoxic T lymphocytes; Gag; HIV 1; Peptide; Primary cytotoxic T lymphocyte induction; Reverse transcriptase; Vaccine

Indexed keywords

CHROMIUM 51; GAG PROTEIN; HLA A ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PEPTIDE; POL PROTEIN; RECOMBINANT PROTEIN; RNA DIRECTED DNA POLYMERASE; VIRUS ENVELOPE PROTEIN;

ALGORITHM; AMINO ACID SEQUENCE; ANTIGEN BINDING; ARTICLE; CELL LINE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE RESPONSE; LYMPHOBLAST; LYMPHOCYTE CLONE; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; PROTEIN BINDING; VACCINIA VIRUS;

EID: 0028802102     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199502000-00002     Document Type: Article

References (59)

1. Kast WM, Melief CJM: In vivo efficacy of virus-derived peptides and virus-specific cytotoxic T lymphocytes, Immunol Lett 1991, 30:229-232.
2. Rötzschke O, Falk K, Deres K, et al.: Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells. Nature 1990, 348:252-254.
3. Townsend ARM, Rothbard J, Gotch FM, Bahadur G, Wraith D, McMichael AJ: The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides. Cell 1986, 44:959-968.
4. b molecule. Nature 1990, 348:213-216.
5. Bjorkmann PJ, Saper MA, Samraoui B, Bennett WS, Strominger JL, Wiley DC: Structure of the human class I histocompatibility antigen, HLA-A2. Nature 1987, 329:506-512.
6. Bjorkmann PJ, Saper MA, Samraoui B, Bennett WS, Strominger JL, Wiley DC: The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens. Nature 1987, 329:512-518.
7. Kast WM, Roux L, Curren J, et al.: Protection against lethal Sendai virus infection by in vivo priming of virus-specific cytotoxic T lymphocytes with a free synthetic peptide. Proc Natl Acad Sci USA 1991, 88:2283-2287.
8. Morrison J, Elvin J, Latron F, Gotch F, Moots R, Strominger JL, McMichael A: Identification of the nonamer peptide from influenza A matrix protein and the role of pockets of HLA-A2 in its recognition by cytotoxic T lymphocytes, Eur J Immunol 1992, 22:903-907.
9. Schulz M, Zinkernagel RM, Hengartner H: Peptide induced antiviral protection by cytotoxic T cells. Proc Natl Acad Sci USA 1991, 88:991-993.
10. van Baalen CA, Klein MR, Geretti AM, et al.: Selective in vitro expansion of HLA class I-restricted HIV-1 Gag-specific CD8+ T cells: cytotoxic T-lymphocyte epitopes and precursor frequencies. AIDS 1993, 7:781-786.
11. Nixon DF, McMichael AJ: Cytotoxic T-cell recognition of HIV proteins and peptides. AIDS 1991, 5:1049-1059.
12. Clerici M: Cell-mediated immunity in HIV infection. AIDS 1993. 7 (suppl 1):S135-S140.
13. Venet A, Walker BD: Cytotoxic T-cell epitopes in HIV/SIV infection. AIDS 1993, 7 (suppl 1):S117-S126.
14. Miedema F, Petit AJC, Terpstra FG, et al: Immunological abnormalities in human immunodeficiency virus (HIV) infected asymptomatic homosexual men. HIV affects the immune systern before CD4+ T-helper cell depletion occurs. J Clin Invest 1988, 82:1908-1914.
15. Gruters RA, Terpstra FG, De Jong R, Van Noesel CJM, Van Lier RAW, Miedema F: Selective loss of T-cell functions in different stages of HIV infection, Eur J Immunol 1990, 20:1039-1044.
16. Terpstra FC, AI BJM, Roos MThL, et al.: Longitudinal study of leukocyte functions in homosexual men seroconverted for HIV: rapid and persistent loss of B-cell function after HIV infection. Eur J Immunol 1989, 19:667-673.
17. Pantaleo G, De Maria A, Koenig S, et al.: CD8+ T lymphocytes of patients with AIDS maintain normal broad cytolytic function despite the loss of human immunodeficiency virus-specific cytotoxicity. Proc Natl Acad Sci USA 1990, 87:4818-4822.
18. Walker CM, Moody DJ, Sittes DP, Levy JA: CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication. Science 1986, 234:1563-1566.
19. Tsubota H, Lord CI, Watkins DI, Morimoto C, Letvin NL: A cytotoxic T lymphocyte inhibits acquired immunodeficiency syndrome virus replication in peripheral blood lymphocytes. J Exp Med 1989, 169:1421-1434.
20. Venet A, Bourgault I, Aubertin AM, Kieny MP, Levy JP: Cytotoxic T-lymphocyte response against multiple simian immunodeficiency virus (SIV) proteins in SIV-infected macaques. J Immunol 1992, 148:2899-2908.
21. Miller MD, Lord CI, Stallard GP, Letvin NL: The gag-specific cytotoxic T lymphocytes in rhesus monkeys infected with the simian immunodeficiency virus of macaques. J Immunol 1990, 144:122-128.
22. Littaua RA, Oldstone MBA, Takeda A, et al.: An HLA-C-restricted CD8+ cytotoxic T-lymphocyte clone recognizes a highly conserved epitope on human immunodeficiency virus type 1 gag. J Virol 1991, 65:4051-4056.
23. Klein MR, Bende RJ, Van Baalen CA, Keet IPM, Eeftinck-Schattenkerk JKM, Miedema F: Persistent high gag CTLp frequency and low viral load in long-term asymptomatic HIV infection. IX International Conference on AIDS. Berlin, June 1993 (abstract WS-B03-3].
24. Harrer E, Harrer T, Buchbinder S, Yilma T, Johnson RP, Walker BD: HIV-specific CTL response in healthy long-term seropositive persons. IX International Conference on AIDS. Berlin, June 1993 [abstract PO-A22-484].
25. Koenig S, Fuerst TR, Wood LV, et al.: Mapping the fine specificity of a cytolytic T cell response to HIV-1 nef protein. J Immunol 1990, 145:127-135.
26. Ratner L: Molecular biology and pathogenesis of HIV infection. Curr Opin Infect Dis 1993, 6:181-190.
27. McNearney T, Hornickova Z, Markham R, et al.: Relationship of human immunodeficiency virus type 1 sequence heterogeneity to stage of disease. Proc Natl Acad Sci USA 1992, 89:10247-10251.
28. Phillips RE, Rowland-Jones S, Nixon DF, et al.: Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature 1991, 354:453-459.
29. Dai L, West K, Littaua R, Takahashi K, Ennis F: Mutation of human immunodeficiency virus type 1 at amino acid 585 on gp41 results in loss of killing by CD8+ A24-restricted cytotoxic T lymphocyte. J Virol 1992, 66:3151-3154.
30. Johnson RP, Trocha A, Buchanan TM, Walker BD: Identification of overlapping HLA class I-restricted cytotoxic T-cell epitopes in a conserved region of the human immunodeficiency virus type 1 envelope glycoprotein: definition of minimum epitopes and analysis of the effects of sequence variation. J Exp Med 1992, 175:961-971.
31. Imanishi T, Akaza T, Kimura A, et al.: Allele and haplotype frequencies for HLA and complement loci in various ethnic groups. In HLA 1991, Proceedings of the Eleventh International Histocompatibility Workshop and Conference. Edited by Tsuji K, Aizawa M, Sasazuki T. Tokyo: Oxford University Press; 1992:1066-1077.
32. Macatonia SE, Taylor PM, Knight SC, Askonas BA: Primary stimulation by dendritic cells induces antiviral proliferative and cytotoxic T-cell responses in vitro. J Exp Med 1989, 169:1255-1264.
33. De Bruijn MLH, Schumacher TNM, Nieland JD, Ploegh HL, Kast WM, Melief CJM: Peptide loading of empty MHC molecules on RMA-S cells allows induction of primary cytotoxic lymphocyte responses. Eur J Immunol 1991, 21:2963-2970.
34. Houbiers JGA, Nijman HW, Van Der Burg SH, et al: In vitro induction of human cytotoxic T-lymphocyte responses against peptides of mutant and wild-type p53. Eur J Immunol 1993, 23:2072-2077.
35. Salter RD, Creswell P: Impaired assembly and transport of HLA-A and -B antigens in a mutant TxB cell hybrid. EMBO J 1986, 5:943-949.
36. Nijman HW, Houbiers JGA, Vierboom MPM, et al.: Identification of peptide sequences that potentially trigger HLA-A2.1 restricted cytotoxic T lymphocytes, Eur J Immunol 1993, 23:1215-1219.
37. Flexner C, Broyles SS, Earl P, Chakrabarti S, Moss B: Characterization of human immunodeficiency virus gag/pol gene products expressed by recombinant vaccinia viruses. Virology 1988, 166:339-349.
38. Chakrabarti S, Brechling K, Moss B: Coexpression of β-galactosidase provides visual screening of recombinant virus plaques. Mol Cell Biol 1985, 5:3403-3409.
39. Horai S, Van De Poel J, Goulmy E: Differential recognition of the serologically defined HLA-A2 antigen by allogeneic cytotoxic T cells, Immunogenetics 1992, 16:135-142.
40. Koning F, Kardol M, Van De Poel J, et al.: The influence of the workshop monoclonal antibodies on CML, AgTR, PLT, ADCC and NK cell activity. Functional studies with workshop antibodies. In Proceedings of the Second International Workshop on Human Leucocyte Differentiation Antigens. Edited by Reinherz EL, Haynes BF, Nadler LM, Bernstein LD. Heidelberg: Springer; 1986:189-203.
41. Myers G, Wain-Hobson S, Korber B, Smith RF, Pavlakis GN (Eds): A compilation and analysis of nucleic acid and amino acid sequences. In Human Retroviruses and AIDS (vol I-II). Los Alamos: Los Alamos National Laboratory; 1993 (section II).
42. Walker BD, Flexner C, Birch-Limberger K, et al.: Long term culture and fine specificity of human cytotoxic T lymphocyte clones reactive with human immunodeficiency virus type 1. Proc Natl Acad Sci USA 1989, 86:9514-9518.
43. Johnson RP, Trocha A, Yang L, et al.: HIV-1 gag-specific cytotoxic T-lymphocyte clones recognize multiple highly conserved epitopes. J Immunol 1991, 147:1512-1521.
44. Melief CJM, Kast WM: Lessons from T-cell responses to virusinduced tumours for cancer eradication in general. Cancer Surv 1992, 13:81-99.
45. Hammond SA, Bollinger RC, Stanhope PE, et al.: Comparative clonal analysis of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ and CD8+ cytolytic T lymphocytes isolated from seronegative humans immunized with candidate HIV-1 vaccines. J Exp Med 1992, 176:1531-1542.
46. Orentas RJ, Hildreth JEK, Obah E, et al.: Induction of CD4+ human cytolytic T cells specific for HIV-infected cells by a gp160 subunit vaccine. Science 1990, 248:1234-1237.
47. DeMaria A, Pantaleo G, Schnittman SM, et al.: Infection of CD8+ T lymphocytes with HIV: requirement for interaction with infected CD4+ cells and induction of infectious virus from chronically infected CD8+ cells. J Immunol 1991, 146:2220-2226.
48. DeMaria A, Colombini S, Schnittman SM, et al.: CD8+ cytolytic T lymphocytes become infected in vitro in the process of killing HIV-1 infected target cells. Eur J Immunol 1994, 24:531-536.
49. Schnittman SM, Psallidopoulos MC, Lane HC et al.: The reservoir for HIV-1 in human peripheral blood is a T cell that maintains expression of CD4. Science 1989, 245:305-308.
50. Louwagie J, McCutchan FE, Peeters M, et al.: Phylogenetic analysis of gag genes from 70 international HIV-1 isolates provides evidence for multiple genotypes. AIDS 1993, 7:769-780.
51. De Bruijn MLH, Nieland JD, Schumacher TNM, Ploegh HL, Kast WM, Melief CJM: Mechanisms of induction of primary virus-specific cytotoxic T lymphocyte responses. Eur J Immunol 1992, 22:3013-3020.
52. Celis E, Tsai V, Crimi C, et al.: Induction of anti-tumor cytotoxic T lymphocytes in normal humans using primary cultures and synthetic peptide epitopes. Proc Natl Acad Sci USA 1994, 91:2105-2109.
53. Feltkamp MCW, Smits HL, Vierboom MPM, et al.: Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells. Eur J Immunol 1993, 23:2242-2249.
54. Larder BA, Purifoy DJM, Powell KL, Darby G: Site-specific mutagenesis of AIDS virus reverse transcriptase. Nature 1987, 327:716-717.
55. Gotch FM, McMichael AJ, Rothbard J: Recognition of influenza matrix protein by HLA-A2-restricted cytotoxic T lymphocytes: use of analogues to orientate the matrix peptide in the HLA-A2 binding site. ; Exp Med 1988, 168:2045-2057.
56. Pircher H, Moskophidis D, Rohrer U, Bürki K, Hengartner H, Zinkernagel RM: Viral escape by selection of cytotoxic T cell-resistant virus variants in vivo. Nature 1990, 346:629-633.
57. Wakefield JK, Jablonski SA, Morrow CD: In vitro enzymatic activity of human immunodeficiency virus type 1 reverse transcriptase mutants in the highly conserved YMDD amino acid motif correlates with the infectious potential of the proviral genome. J Virol 1992, 66:6806-6812.
58. b mutant bm-13 mice. J Virol 1994, 68:6038-6046.
59. Miller MD, Gould-Fogerite S, Shen L, et al.: Vaccination of rhesus monkeys with synthetic peptide in a fusogenic proteoliposome elicits simian immunodeficiency virus-specific CD8+ cytotoxic T lymphocytes. J Exp Med 1992, 176:1739-1744.